- ANORO is contraindicated in patients with severe hypersensitivity to milk proteins or with hypersensitivity to umeclidinium, vilanterol, or any of the excipients.
ANORO is for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
ANORO is NOT for the relief of acute bronchospasm or for asthma.
You are about to leave a GSK website. By clicking this link, you will be taken to a website that is independent from GSK. The site you are linking to is not controlled or endorsed by GSK, and GSK is not responsible for its content.